title: Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.
authors.affiliation: Department of Anesthisiology, Sint Maartenskliniek, Nijmegen, The Netherlands. r.slappendel@maartenskliniek.nl
authors.forename: Robert
authors.initials: R
authors.lastname: Slappendel
authors.forename: Frank C
authors.initials: FC
authors.lastname: Huvers
authors.forename: Bart
authors.initials: B
authors.lastname: Benraad
authors.forename: Irena
authors.initials: I
authors.lastname: Novàkova
authors.forename: Gijs G
authors.initials: GG
authors.lastname: van Hellemondt
mesh_terms: D019644:Arthroplasty, Replacement, Hip; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013917:Thrombin / Q000096:biosynthesis; D013921:Thrombocytopenia / Q000097:blood*
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa; D013917:Thrombin